BioCentury
ARTICLE | Company News

Advirna LLC, RXi Pharmaceuticals deal

August 3, 2009 7:00 AM UTC

RXi exercised its option for exclusive, worldwide rights to four of Advirna's RNAi delivery technologies. RXi said its primary focus is on "self-delivery," which does not require a separate delivery v...